Aurora Cannabis

ACB-T

TSE:ACB

2.60
0.12 (4.84%)
Aurora Cannabis Inc. is a Canadian licensed cannabis producer, headquartered in Edmonton. It trades on the Toronto Stock Exchange as ACB. As of late September 2018, Aurora Cannabis had eight licensed production facilities, five sales licences, and operations in 18 countries.
More at Wikipedia

Analysis and Opinions about ACB-T

Signal
Opinion
Expert
DON'T BUY
DON'T BUY
December 18, 2019
He feels all cannabis stocks are gambling stocks. A maturing debenture is expected to keep downward pressure on the share price. There is no assurance that any existing company will be a survivor -- it is simply too early. No one is making money in this space. Without being able to predict revenues and expenses, it is too risky. He would stay away from these.
Show full opinionHide full opinion
Aurora Cannabis (ACB-T)
December 18, 2019
He feels all cannabis stocks are gambling stocks. A maturing debenture is expected to keep downward pressure on the share price. There is no assurance that any existing company will be a survivor -- it is simply too early. No one is making money in this space. Without being able to predict revenues and expenses, it is too risky. He would stay away from these.
DON'T BUY
DON'T BUY
December 4, 2019
The cannabis sector has been thrashed and still not good value--no earnings, uncertain sales. Very risky and good luck to you. He doesn't see the fundamentals improving.
Show full opinionHide full opinion
Aurora Cannabis (ACB-T)
December 4, 2019
The cannabis sector has been thrashed and still not good value--no earnings, uncertain sales. Very risky and good luck to you. He doesn't see the fundamentals improving.
DON'T BUY
DON'T BUY
November 12, 2019
They're reporting soon. There's a lot of oversupply in the sector; the black market sells cheaper weed and legal distribution is tight. This industry is still evolving. There was a lot of froth before in this space. Also, the laws keep changing. Weed companies aren't making money. She's sitting on the sidelines.
Show full opinionHide full opinion
Aurora Cannabis (ACB-T)
November 12, 2019
They're reporting soon. There's a lot of oversupply in the sector; the black market sells cheaper weed and legal distribution is tight. This industry is still evolving. There was a lot of froth before in this space. Also, the laws keep changing. Weed companies aren't making money. She's sitting on the sidelines.
DON'T BUY
DON'T BUY
October 30, 2019
Cannabis? He is fortunate that they have not participated in the cannabis space over the past year. It is just too difficult to determine who will be the winners in this space just yet. A lot of companies will short on cash. ACB has a $200 million debenture coming due in March 2020, which will have to be refinanced as the strike price is well above current prices. Stay away from ACB. He would not buy anything in the space.
Show full opinionHide full opinion
Aurora Cannabis (ACB-T)
October 30, 2019
Cannabis? He is fortunate that they have not participated in the cannabis space over the past year. It is just too difficult to determine who will be the winners in this space just yet. A lot of companies will short on cash. ACB has a $200 million debenture coming due in March 2020, which will have to be refinanced as the strike price is well above current prices. Stay away from ACB. He would not buy anything in the space.
COMMENT
COMMENT
October 22, 2019
Short this to $1? $4.50 is its book value and technical support. Has a strong balance sheet, but it has no earnings or fair market value. We're at the stage in cannabis where these stocks have to prove they can survive as a business. Don't short this anymore. The price is so low it's starting to look attractive.
Show full opinionHide full opinion
Aurora Cannabis (ACB-T)
October 22, 2019
Short this to $1? $4.50 is its book value and technical support. Has a strong balance sheet, but it has no earnings or fair market value. We're at the stage in cannabis where these stocks have to prove they can survive as a business. Don't short this anymore. The price is so low it's starting to look attractive.
DON'T BUY
DON'T BUY
October 8, 2019

His weed exposure is through Constellation Brands which owns Canopy--this is less risky than owning cannabis stocks. The valuation on the entire sector rose way too high in 2017-8. Now, the industry is feeling growing pains, with unexpected surprises in working with governments. Generally sin stocks do well long term, but the next year or two will be challenging.

Show full opinionHide full opinion
Aurora Cannabis (ACB-T)
October 8, 2019

His weed exposure is through Constellation Brands which owns Canopy--this is less risky than owning cannabis stocks. The valuation on the entire sector rose way too high in 2017-8. Now, the industry is feeling growing pains, with unexpected surprises in working with governments. Generally sin stocks do well long term, but the next year or two will be challenging.

DON'T BUY
DON'T BUY
October 7, 2019
Cannabis stocks are continuing to go down. They went up on hype and spiked around the time it became legal in Canada. They are having trouble getting their product out and displacing the black market. There is nothing to keep these stocks from going lower. There is tax loss selling coming.
Show full opinionHide full opinion
Aurora Cannabis (ACB-T)
October 7, 2019
Cannabis stocks are continuing to go down. They went up on hype and spiked around the time it became legal in Canada. They are having trouble getting their product out and displacing the black market. There is nothing to keep these stocks from going lower. There is tax loss selling coming.
HOLD
HOLD
September 20, 2019
One of the top four producers of cannabis in Canada. Back to fundamentals, you have to demonstrate the ability to make money. The company has not "super stumbled", but it is not lighting a fire. Trading at 8 times revenue, this space in general requires very high growth rates. It is one of the seniors in the space, so if you like this area it is one to hold.
Show full opinionHide full opinion
Aurora Cannabis (ACB-T)
September 20, 2019
One of the top four producers of cannabis in Canada. Back to fundamentals, you have to demonstrate the ability to make money. The company has not "super stumbled", but it is not lighting a fire. Trading at 8 times revenue, this space in general requires very high growth rates. It is one of the seniors in the space, so if you like this area it is one to hold.
DON'T BUY
DON'T BUY
August 20, 2019
The cannabis trade is over and only day traders are in this space. And this will shrink. Cannabis have invested a lot in projects that won't make money. Avoid this sector.
Show full opinionHide full opinion
Aurora Cannabis (ACB-T)
August 20, 2019
The cannabis trade is over and only day traders are in this space. And this will shrink. Cannabis have invested a lot in projects that won't make money. Avoid this sector.
COMMENT
COMMENT
July 9, 2019
Like all cannabis, it's struggling now. The chart is very short, so he has little to analyze. He can't compare this to Canopy; they're too different.
Show full opinionHide full opinion
Like all cannabis, it's struggling now. The chart is very short, so he has little to analyze. He can't compare this to Canopy; they're too different.
DON'T BUY
DON'T BUY
June 21, 2019
And the cannabis space in general He doesn't follow cannabis. These companies won't make money for a while as they spend on production capacity and staff. Also, the black market remains as big or bigger than the legal. He's waiting to see how this space shakes out. It's like the dot-com bubble.
Show full opinionHide full opinion
And the cannabis space in general He doesn't follow cannabis. These companies won't make money for a while as they spend on production capacity and staff. Also, the black market remains as big or bigger than the legal. He's waiting to see how this space shakes out. It's like the dot-com bubble.
DON'T BUY
DON'T BUY
May 6, 2019
Has a good uptrend, but is now sideway at $12. If it doesn't hold at $12, it will head south. Look at Canopy instead, the biggest name.
Show full opinionHide full opinion
Has a good uptrend, but is now sideway at $12. If it doesn't hold at $12, it will head south. Look at Canopy instead, the biggest name.
SPECULATIVE BUY
SPECULATIVE BUY
March 18, 2019
He does not dig into their product but hopes to use it medically some day. For him it is the medical side that will be massive. He does not think there is a whole lot of upside. He would be a big buyer at $6. It is speculative right now.
Show full opinionHide full opinion
Aurora Cannabis (ACB-T)
March 18, 2019
He does not dig into their product but hopes to use it medically some day. For him it is the medical side that will be massive. He does not think there is a whole lot of upside. He would be a big buyer at $6. It is speculative right now.
WAIT
WAIT
March 11, 2019
He is excited about the long term prospects from the health prospects of the industry. This is a medical play for him. He thinks they are pricing for 5 to 10 years from now. The sector will be very investible for the next decade after the next economic downturn where those with questionable outlooks will get hammered.
Show full opinionHide full opinion
Aurora Cannabis (ACB-T)
March 11, 2019
He is excited about the long term prospects from the health prospects of the industry. This is a medical play for him. He thinks they are pricing for 5 to 10 years from now. The sector will be very investible for the next decade after the next economic downturn where those with questionable outlooks will get hammered.
COMMENT
COMMENT
January 28, 2019
This space is starting to bottom out, but still a year or more to be a big deal. But the risk is off and volatility is lessening. He's starting to like these stocks.
Show full opinionHide full opinion
Aurora Cannabis (ACB-T)
January 28, 2019
This space is starting to bottom out, but still a year or more to be a big deal. But the risk is off and volatility is lessening. He's starting to like these stocks.
Showing 1 to 15 of 71 entries